BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37138122)

  • 1. Potential functions and therapeutic implications of glioma-resident mesenchymal stem cells.
    Zhang Q; Wang J; Zhang J; Liu F
    Cell Biol Toxicol; 2023 Jun; 39(3):853-866. PubMed ID: 37138122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
    Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
    Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
    Cui X; Liu J; Bai L; Tian J; Zhu J
    Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells.
    Dai X; Wang Y; Dong X; Sheng M; Wang H; Shi J; Sheng Y; Liu L; Jiang Q; Chen Y; Wu B; Yang X; Cheng H; Kang C; Dong J
    Aging (Albany NY); 2020 May; 12(10):9151-9172. PubMed ID: 32452829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD90
    Xue BZ; Xiang W; Zhang Q; Wang HF; Zhou YJ; Tian H; Abdelmaksou A; Xue J; Sun MX; Yi DY; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2021 Jul; 12(1):394. PubMed ID: 34256854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.
    Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F
    Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
    Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
    Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
    Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
    PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
    J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade.
    Antoon R; Wang XH; Saleh AH; Warrington J; Hedley DW; Keating A
    Cytotherapy; 2022 Jul; 24(7):699-710. PubMed ID: 35473998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
    Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
    Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal communication in glioma - a review.
    Xu H; Zhang K; Zong H; Shang M; Li K; He X
    J BUON; 2016; 21(6):1368-1373. PubMed ID: 28039693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome.
    Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
    Whiteside TL
    Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
    Frisbie L; Buckanovich RJ; Coffman L
    Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.
    Al-Kharboosh R; ReFaey K; Lara-Velazquez M; Grewal SS; Imitola J; Quiñones-Hinojosa A
    Mayo Clin Proc Innov Qual Outcomes; 2020 Aug; 4(4):443-459. PubMed ID: 32793872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion between Glioma Stem Cells and Mesenchymal Stem Cells Promotes Malignant Progression in 3D-Bioprinted Models.
    Dai X; Shao Y; Tian X; Cao X; Ye L; Gao P; Cheng H; Wang X
    ACS Appl Mater Interfaces; 2022 Aug; 14(31):35344-35356. PubMed ID: 35881920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.
    Cui X; Jing X; Yi Q; Xiang Z; Tian J; Tan B; Zhu J
    Oncol Rep; 2019 Apr; 41(4):2148-2158. PubMed ID: 30816520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.